DCSVX | VISVX | DCSVX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 26 years | - |
Gain YTD | 6.651 | 11.310 | 59% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 3000 | 167% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 106M | 57.3B | 0% |
Annual Yield % from dividends | 0.00 | 1.90 | - |
Returns for 1 year | 18.52 | 25.80 | 72% |
Returns for 3 years | -9.52 | 21.42 | -44% |
Returns for 5 years | 7.17 | 56.98 | 13% |
Returns for 10 years | -2.18 | 108.54 | -2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDGT | 78.48 | 0.34 | +0.44% |
iShares U.S. Digital Infras & RE ETF | |||
TPYP | 31.59 | 0.12 | +0.40% |
Tortoise North American Pipeline | |||
BOND | 94.83 | 0.32 | +0.34% |
PIMCO Active Bond ETF | |||
GERM | 19.16 | N/A | N/A |
Amplify Treatments Testing and Advancements ETF | |||
CWS | 68.27 | -0.25 | -0.36% |
AdvisorShares Focused Equity ETF |